Virtu Pharmako
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- Undisclosed
Investors
- 1
About Virtu Pharmako
Founded in 2021, and based in Jiaxing, China, Virtu Pharmako is an innovative biopharmaceutical developer that specializes in biopharmaceuticals, primarily GLP-1 analogs and insulin products. The company has cooperated with Huazhong Agricultural University and has a branch office in America. Virtu Pharmako specializes in the development and production of innovative biopharmaceutical products, primarily focusing on GLP-1 analogs, insulin products, and recombinant enzymes. These products are designed to address various medical conditions, including metabolic diseases and cancer treatment, and are marketed to healthcare providers and pharmaceutical companies in both domestic and international markets, particularly in North America and Europe. The company generate revenue by selling biopharmaceutical products, including GLP-1 and insulin-based therapies, typically structured as wholesale agreements and supply contracts. Collaborations with academic institutions also enhance revenue generation through research initiatives. The company is focused on launching new products designed for chronic conditions, with specific plans to expand into North American and European markets by mid-2025, aiming to enhance its product offerings and market presence.
Who invested in Virtu Pharmako
1 investor across 2 rounds
See all investors in Virtu Pharmako
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Virtu Pharmako
Who invested in Virtu Pharmako?
Virtu Pharmako has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Virtu Pharmako raised?
Virtu Pharmako has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Virtu Pharmako last raise money?
Virtu Pharmako's most recent round on record is a Series A, in Oct 2024.
What does Virtu Pharmako do?
Founded in 2021, and based in Jiaxing, China, Virtu Pharmako is an innovative biopharmaceutical developer that specializes in biopharmaceuticals, primarily GLP-1 analogs and insulin products.
Where is Virtu Pharmako headquartered?
Virtu Pharmako is headquartered in Jiaxing, China.
Which VCs invest in companies like Virtu Pharmako?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Virtu Pharmako's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Virtu Pharmako? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.